Identifying depression in people with aphasia using laboratory tests

Validating non-linguistic laboratory biomarkers of depression in persons with aphasia

NIH-funded research Rehabilitation Institute of Chicago D/b/a Shirley Ryan Abilitylab · NIH-10987275

This study is looking for better ways to spot depression in people with aphasia, who have trouble with language, by using simple tests that measure things like heart rate and eye movements instead of traditional questionnaires.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionRehabilitation Institute of Chicago D/b/a Shirley Ryan Abilitylab NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-10987275 on NIH RePORTER

What this research studies

This research investigates how to effectively identify depression in individuals with aphasia, a condition that affects language abilities. Traditional methods of assessing depression, such as questionnaires, are challenging for these patients due to their language difficulties. Instead, the study will explore three laboratory-based biomarkers—heart-rate variability, pupil dilation, and gaze duration—to see if they can reliably indicate depression in this population. By using these non-linguistic measures, the research aims to improve the diagnosis and treatment of depression in individuals with aphasia.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with aphasia who may also be experiencing symptoms of depression.

Not a fit: Patients without aphasia or those who do not exhibit depressive symptoms may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and accessible methods for diagnosing depression in individuals with aphasia, ultimately improving their quality of life.

How similar studies have performed: While the use of laboratory biomarkers for depression assessment is gaining interest, this specific approach in aphasia patients is relatively novel and has not been extensively tested.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.